NOT_YET_RECRUITING
EHR Nudges to Improve Quality of Care in HF
The purpose of this pilot feasibility study is to test a pharmacist-facing clinical decision support tool designed to increase adherence to guideline-directed medical therapy and evaluate the tool using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation framework.
Conditions:
🦠 Heart Failure With Reduced Ejection Fraction
🗓️ Study Start (Actual) 12 August 2024
🗓️ Primary Completion (Estimated) 31 March 2025
✅ Study Completion (Estimated) 1 July 2025
👥 Enrollment (Estimated) 5
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Pharmacist at Northwestern Medicine participating in the Medication Adjusted to Target (MAT) Clinic

    Exclusion Criteria:

    • * None
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 23 October 2023
  • First Submitted that Met QC Criteria 23 October 2023
  • First Posted 27 October 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 18 July 2024
  • Last Update Posted 19 July 2024
  • Last Verified July 2024